BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mennuni MG, Renda G, Grisafi L, Rognoni A, Colombo C, Lio V, Foglietta M, Petrilli I, Pirisi M, Spinoni E, Azzolina D, Hayden E, Aimaretti G, Avanzi GC, Bellan M, Cantaluppi V, Capponi A, Castello LM, D'Ardes D, Corte FD, Gallina S, Krengli M, Malerba M, Pierdomenico SD, Savoia P, Zeppegno P, Sainaghi PP, Cipollone F, Patti G; COVID-UPO Clinical Team. Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19. J Thromb Thrombolysis 2021. [PMID: 33649979 DOI: 10.1007/s11239-021-02401-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Duo H, Li Y, Sun Y, Wei L, Wang Z, Fang F, Zhong Y, Huang J, Luo L, Peng Z, Pan H. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis. Thromb J 2022;20:47. [PMID: 35999599 DOI: 10.1186/s12959-022-00408-9] [Reference Citation Analysis]
2 Fragkou PC, Palaiodimou L, Stefanou MI, Katsanos AH, Lambadiari V, Paraskevis D, Andreadou E, Dimopoulou D, Zompola C, Ferentinos P, Vassilakopoulos TI, Kotanidou A, Sfikakis PP, Tsiodras S, Tsivgoulis G. Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients. Ther Adv Neurol Disord 2022;15:175628642210994. [DOI: 10.1177/17562864221099472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 ICM-VTE General Delegates. Recommendations from the ICM-VTE: General. J Bone Joint Surg Am 2022;104:4-162. [PMID: 35315607 DOI: 10.2106/JBJS.21.01531] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Renda G, Ricci F, Spinoni EG, Grisafi L, D’ardes D, Mennuni M, Tana C, Rognoni A, Bellan M, Sainaghi PP, Pirisi M, De Vecchi S, Gallina S, Pierdomenico SD, Cipollone F, Patti G. Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19. JCM 2022;11:729. [DOI: 10.3390/jcm11030729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhang S, Li Y, Liu G, Su B. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis. Thromb J 2021;19:91. [PMID: 34819094 DOI: 10.1186/s12959-021-00343-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kieninger M, Sinning A, Vadász T, Gruber M, Gronwald W, Zeman F, Lunz D, Dienemann T, Schmid S, Graf B, Lubnow M, Müller T, Holzmann T, Salzberger B, Kieninger B. Lower blood pH as a strong prognostic factor for fatal outcomes in critically ill COVID-19 patients at an intensive care unit: A multivariable analysis. PLoS One 2021;16:e0258018. [PMID: 34587211 DOI: 10.1371/journal.pone.0258018] [Reference Citation Analysis]
7 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. The Role of Alveolar Edema in COVID-19. Cells 2021;10:1897. [PMID: 34440665 DOI: 10.3390/cells10081897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Vergori A, Lorenzini P, Cozzi-Lepri A, Donno DR, Gualano G, Nicastri E, Iacomi F, Marchioni L, Campioni P, Schininà V, Cicalini S, Agrati C, Capobianchi MR, Girardi E, Ippolito G, Vaia F, Petrosillo N, Antinori A, Taglietti F; ReCOVeRI Study Group. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep 2021;11:11334. [PMID: 34059708 DOI: 10.1038/s41598-021-90713-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]